Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial.
|
31699568 |
2020 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes.
|
30685100 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.
|
31017470 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome.
|
31399624 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome.
|
30808220 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Methods and Results We measured baseline serum beta- CT x, NT -pro BNP (N-terminal pro-B-type natriuretic peptide), hsTnT (high-sensitivity cardiac troponin T) and hs CRP (high-sensitivity C-reactive protein) (Roche Diagnostics) in a nested biomarker analysis (n=4094) from a study of patients with non- ST -elevation acute coronary syndrome.
|
31020897 |
2019 |
Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The C-reactive protein (CRP) levels obtained at hospital admission are associated with the prognosis of several cardiovascular diseases, including acute coronary syndrome.
|
31104078 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome.
|
31144514 |
2019 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes.
|
30268067 |
2018 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
In 581 patients undergoing coronary angiography for acute coronary syndrome (ACS) or stable angina pectoris, preprocedural blood samples were drawn for fibrinogen, C-reactive protein (CRP), interleukin-6, and plasminogen activator inhibitor-1 measurements, and virtual histology-intravascular ultrasound of a nonculprit coronary artery was performed.
|
27755007 |
2017 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
To determine if vitamin D deficiency was associated with higher odds of left ventricular dysfunction among patients with acute coronary syndrome (ACS) and, if so, to determine whether this association was mediated by increased inflammation as measured by C-reactive protein (CRP) and white blood cell count (WBC).
|
29118583 |
2017 |
Acute Coronary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Relationship Between C-Reactive Protein Serum Concentration and the 1846 C>T (rs1205) Polymorphism in Patients with Acute Coronary Syndrome from Western Mexico.
|
28277782 |
2017 |
Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Of all HHV levels, only CMV was higher in patients with stable coronary artery disease and acute coronary syndrome than in the healthy group, and its load correlated with the level of high-sensitivity C-reactive protein.
|
27543799 |
2016 |
Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
|
24709882 |
2014 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome.
|
24839357 |
2014 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome.
|
23305094 |
2013 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
The concentration of CRP was similar in patients with stable CAD and in controls, but increased in patients presenting with acute coronary syndromes.
|
21310412 |
2011 |
Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In six additional patients (SA=3 and ACS=3), subjected to coronary atherectomy, real-time quantitative PCR revealed presence of CRP mRNA only in unstable plaques.
|
21794939 |
2011 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
LHGDN |
On treatment CRP measurement may therefore offer additive prognostic information to lipids in ACS patients.
|
19122170 |
2009 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
The concentration of C-reactive protein was similar in patients with stable CAD and in controls, but increased in patients presenting with acute coronary syndromes.
|
18499652 |
2009 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
LHGDN |
C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome.
|
18957790 |
2008 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
LHGDN |
Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes.
|
18200582 |
2008 |
Acute Coronary Syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Assessment of CRP genetic variants identified patients with higher and lower CRP elevation after acute coronary syndrome.
|
17044845 |
2006 |
Acute Coronary Syndrome
|
0.400 |
Biomarker
|
disease |
CTD_human |
We examined serum levels of Cu, Fe, Zn and Se, as well as glutathione peroxidase (GPx), a selenoenzyme with antioxidant properties, and C-reactive protein (CRP), a marker of inflammation, in acute coronary syndromes (ACS) regarding their relationship to cardiac troponins and creatine kinase-MB mass (CK-MBm), important prognostic markers.
|
15966572 |
2005 |
Acute Coronary Syndrome
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Tumor necrosis factor-related apoptosis-inducing ligand is expressed in plaque-infiltrating CD3 cells and induced by oxLDL, whereas levels of soluble TRAIL are reduced in patients with acute coronary syndromes and negatively correlate with C-reactive protein levels.
|
15808757 |
2005 |